Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IBPKI
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2023173132A1 ADC-20
|
|||||
| Synonyms |
ADC-20
Click to Show/Hide
|
|||||
| Organization |
REGENERON PHARMACEUTICALS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.2
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
P8 Payload
|
Payload Info | ||||
| Linker Name |
BCN-PEG4-triazole
|
Linker Info | ||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
BCN-PEG4-triazole-P8
|
|||||